AXA SA (AXA.DE) Stock Fundamental Analysis
FRA:AXA - Deutsche Boerse Ag - FR0000120628 - Common Stock - Currency: EUR
Taking everything into account, AXA scores 5 out of 10 in our fundamental rating. AXA was compared to 32 industry peers in the Insurance industry. AXA has only an average score on both its financial health and profitability. AXA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
AXA had positive earnings in the past year.
AXA had a positive operating cash flow in the past year.
AXA had positive earnings in each of the past 5 years.
In the past 5 years AXA always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 1.12%, AXA perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
AXA has a Return On Equity of 15.16%. This is in the better half of the industry: AXA outperforms 66.67% of its industry peers.
With a decent Return On Invested Capital value of 1.32%, AXA is doing good in the industry, outperforming 63.33% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AXA is in line with the industry average of 2.08%.
The 3 year average ROIC (1.23%) for AXA is below the current ROIC(1.32%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.12% | ||
| ROE | 15.16% | ||
| ROIC | 1.32% |
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%
1.3 Margins
AXA's Profit Margin of 8.20% is in line compared to the rest of the industry. AXA outperforms 46.67% of its industry peers.
AXA's Profit Margin has improved in the last couple of years.
AXA's Operating Margin of 11.69% is fine compared to the rest of the industry. AXA outperforms 63.33% of its industry peers.
In the last couple of years the Operating Margin of AXA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.69% | ||
| PM (TTM) | 8.2% | ||
| GM | N/A |
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
AXA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AXA has less shares outstanding
AXA has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AXA has about the same debt to assets ratio.
2.2 Solvency
AXA has an Altman-Z score of 0.34. This is a bad value and indicates that AXA is not financially healthy and even has some risk of bankruptcy.
AXA has a Altman-Z score of 0.34. This is amongst the best in the industry. AXA outperforms 86.67% of its industry peers.
The Debt to FCF ratio of AXA is 3.32, which is a good value as it means it would take AXA, 3.32 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AXA (3.32) is comparable to the rest of the industry.
AXA has a Debt/Equity ratio of 0.57. This is a neutral value indicating AXA is somewhat dependend on debt financing.
The Debt to Equity ratio of AXA (0.57) is better than 63.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 3.32 | ||
| Altman-Z | 0.34 |
ROIC/WACC0.13
WACC10.16%
2.3 Liquidity
AXA has a Current Ratio of 1.00. This is a normal value and indicates that AXA is financially healthy and should not expect problems in meeting its short term obligations.
AXA's Current ratio of 1.00 is amongst the best of the industry. AXA outperforms 86.67% of its industry peers.
A Quick Ratio of 1.00 indicates that AXA should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.00, AXA belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
AXA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.49%, which is quite good.
Measured over the past years, AXA shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.03% on average per year.
AXA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.35%.
The Revenue has been decreasing by -4.60% on average over the past years.
EPS 1Y (TTM)17.49%
EPS 3Y35.79%
EPS 5Y32.03%
EPS Q2Q%4.47%
Revenue 1Y (TTM)-11.35%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Sales Q2Q%-21.85%
3.2 Future
The Earnings Per Share is expected to grow by 5.80% on average over the next years.
The Revenue is expected to grow by 5.65% on average over the next years.
EPS Next Y6.81%
EPS Next 2Y8.71%
EPS Next 3Y7.94%
EPS Next 5Y5.8%
Revenue Next Year-13.58%
Revenue Next 2Y-4.81%
Revenue Next 3Y-3.63%
Revenue Next 5Y5.65%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.47, the valuation of AXA can be described as very reasonable.
Based on the Price/Earnings ratio, AXA is valued a bit cheaper than 66.67% of the companies in the same industry.
AXA is valuated cheaply when we compare the Price/Earnings ratio to 28.47, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 9.22, which indicates a very decent valuation of AXA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AXA is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of AXA to the average of the S&P500 Index (92.74), we can say AXA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.47 | ||
| Fwd PE | 9.22 |
4.2 Price Multiples
The rest of the industry has a similar Price/Free Cash Flow ratio as AXA.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.15 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of AXA may justify a higher PE ratio.
PEG (NY)1.68
PEG (5Y)0.36
EPS Next 2Y8.71%
EPS Next 3Y7.94%
5. Dividend
5.1 Amount
AXA has a Yearly Dividend Yield of 5.40%, which is a nice return.
Compared to an average industry Dividend Yield of 5.01, AXA has a dividend in line with its industry peers.
AXA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.4% |
5.2 History
The dividend of AXA has a limited annual growth rate of 4.19%.
Dividend Growth(5Y)4.19%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
62.10% of the earnings are spent on dividend by AXA. This is not a sustainable payout ratio.
The dividend of AXA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.1%
EPS Next 2Y8.71%
EPS Next 3Y7.94%
AXA SA
FRA:AXA (2/4/2025, 7:00:00 PM)
37.04
+0.69 (+1.9%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners41.04%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap82.01B
Analysts80.71
Price Target40.44 (9.18%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.4% |
Yearly Dividend1.76
Dividend Growth(5Y)4.19%
DP62.1%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.12%
PT rev (3m)2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.22%
EPS NY rev (3m)0.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.43%
Revenue NY rev (3m)-4.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.47 | ||
| Fwd PE | 9.22 | ||
| P/S | 0.94 | ||
| P/FCF | 10.15 | ||
| P/OCF | 9.58 | ||
| P/B | 1.73 | ||
| P/tB | 3.35 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.23
EY8.72%
EPS(NY)4.02
Fwd EY10.84%
FCF(TTM)3.65
FCFY9.85%
OCF(TTM)3.87
OCFY10.44%
SpS39.51
BVpS21.38
TBVpS11.07
PEG (NY)1.68
PEG (5Y)0.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.12% | ||
| ROE | 15.16% | ||
| ROCE | 1.63% | ||
| ROIC | 1.32% | ||
| ROICexc | 1.37% | ||
| ROICexgc | 1.79% | ||
| OM | 11.69% | ||
| PM (TTM) | 8.2% | ||
| GM | N/A | ||
| FCFM | 9.24% |
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%
ROICexc(3y)1.28%
ROICexc(5y)1.05%
ROICexgc(3y)1.64%
ROICexgc(5y)1.33%
ROCE(3y)1.52%
ROCE(5y)1.25%
ROICexcg growth 3Y24.63%
ROICexcg growth 5Y6.98%
ROICexc growth 3Y21.16%
ROICexc growth 5Y7.2%
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 3.32 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.55% | ||
| Interest Coverage | 1.51 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 112.61% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 0.34 |
F-Score7
WACC10.16%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.37%
Cap/Sales(5y)0.36%
Profit Quality(3y)112.32%
Profit Quality(5y)257.76%
High Growth Momentum
Growth
EPS 1Y (TTM)17.49%
EPS 3Y35.79%
EPS 5Y32.03%
EPS Q2Q%4.47%
EPS Next Y6.81%
EPS Next 2Y8.71%
EPS Next 3Y7.94%
EPS Next 5Y5.8%
Revenue 1Y (TTM)-11.35%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Sales Q2Q%-21.85%
Revenue Next Year-13.58%
Revenue Next 2Y-4.81%
Revenue Next 3Y-3.63%
Revenue Next 5Y5.65%
EBIT growth 1Y4.29%
EBIT growth 3Y12.44%
EBIT growth 5Y-0.05%
EBIT Next Year26.06%
EBIT Next 3Y9.55%
EBIT Next 5YN/A
FCF growth 1Y9.42%
FCF growth 3Y-33.47%
FCF growth 5Y-1.8%
OCF growth 1Y11.23%
OCF growth 3Y-32.45%
OCF growth 5Y-1.79%